A significant body of research highlights on targeting CCL2/MCP-1, a key chemokine implicated in various inflammatory disorders. Existing approaches frequently encounter challenges relating to poor https://www.targetmol.com/compound/anti-mouse-rat-human-ccl2-mcp-1-antibody-2h5